Ph.D., Faculty of Health Sciences, University of the Witwatersrand, 2011 / Contemporary notions of the adverse effects of blood pressure (BP) incorporate the
increasingly recognised damaging effects of not only distending pressure (indexed by mean
arterial pressure-MAP) but also pulse pressure (PP) (the difference between systolic and
diastolic BP) on the cardiovascular system. Although the factors which determine brachial
artery PP are similar to those affecting central (aortic) PP (PPc), some factors may affect
central PP preferentially, and thus PP calculated from brachial artery BP measurement may
not closely reflect the PP that accounts for cardiovascular damage. In order that therapeutic
strategies are developed that modify PPc independent of distending pressures, there is
considerable interest in the pathophysiological mechanisms that explain increases in PPc. In
this regard, aortic PP is comprised of the forward or incident pressure component (P1), which
is largely determined by stroke volume, aortic compliance or stiffness and aortic diameter;
and the augmented pressure component (AP), which is determined by wave reflection.
Whilst currently employed antihypertensive agents may modify AP independent of distending
pressures, there is little evidence to indicate a similar effect on the structural aortic changes
responsible for P1.
Although changes in AP as opposed to P1 largely account for age-related increases
in PPc across the adult lifespan in normotensives, the relative contribution of AP and P1 to
PPc in communities with a high prevalence of uncontrolled BP is unknown. In 1015 randomly
recruited participants (range 16-88 years) from a community sample, 37.7% of whom had
uncontrolled BP, I demonstrated that independent of MAP and other confounders, P1
contributes as much as AP to age-related increases in PPc and to variations in PPc across
the adult lifespan.
As no previous studies have assessed the relationship between P1 and
cardiovascular damage, in 503 randomly recruited participants from a community with a high
prevalence of uncontrolled BP, the relative contribution of P1 and AP to increases in left
ventricular mass index (LVMI) was subsequently evaluated. In this regard, independent of
distending pressures, P1 was associated with LVMI, highlighting the need to understand the
iii
potential mechanisms which contribute to P1. Could the pathophysiological mechanisms that
determine hypertension account for the contribution of P1 to PPc? In this regard, I evaluated
the potential role of three mechanisms.
First, in 635 randomly selected participants with 24-hour urine samples that met with
pre-specified quality control criteria, I provide the first data to demonstrate that urinary
sodium-to-potassium ratio (an index of Na+ and K+ intake) is independently associated with
PPc, but not brachial PP independent of distending pressures, a relationship that could be
accounted for by changes in both AP and P1, but not aortic pulse wave velocity. Second, I
explored the possibility that low grade inflammation as indexed by circulating high-sensitivity
C-reactive protein concentrations (hs-CRP) may contribute toward PPc and the component
pressures. In this regard, although hs-CRP has been associated with changes in central
haemodynamics in small study samples, in a large community sample of participants these
findings could not be reproduced. However, in that study the community had a low
prevalence of risk-related hs-CRP concentrations. In 836 randomly recruited participants
from a population sample with a high prevalence of risk-related hs-CRP concentrations
(~57%), although on univariate analysis I showed that hs-CRP was strongly associated with
PPc and the component pressures, this relationship did not persist with adjustments for
confounders. Last I evaluated the potential contribution of genetic factors toward PPc and the
component pressures. Although three prior studies had demonstrated heritability of PPc, AP
and P1, two studies failed to adjust for MAP and a third assessed the heritability in females
only. In none of these studies was the contribution of aortic PWV to the heritability estimates
of PPc, AP and P1 assessed. In 568 participants from 183 nuclear families, I showed that
independent of MAP, multivariable adjusted PPc, AP, P1 and PWV aggregated in families
and were inherited. However, adjustments for aortic PWV failed to modify the extent of intrafamilial
aggregation and heritability of PPc, AP, or P1.
In conclusion, in the present thesis I have advanced our understanding of the
mechanisms responsible for increases in PPc. In this regard, I provide evidence to suggest
that independent of distending pressures and stroke volume, P1 accounts for a significant
iv
proportion of the age-related increases in PPc and the variability of PPc across the adult
lifespan in communities with a high prevalence of uncontrolled hypertension; that P1
contributes substantially to the relationship between PPc and LVMI; and that PPc and both
the AP and P1 component pressures are associated with a urinary index of salt intake as
well as genetic factors, but not to an index of low-grade inflammation. These findings suggest
that to achieve optimal cardiovascular risk reduction in hypertension, therapeutic strategies
that target the aortic structural changes responsible for P1 are likely to be required across
the adult lifespan, and that this therapy must in-part address the impact of salt intake and
genetic factors, but not necessarily low-grade inflammation on PPc.
| Identifer | oai:union.ndltd.org:netd.ac.za/oai:union.ndltd.org:wits/oai:wiredspace.wits.ac.za:10539/11542 |
| Date | 15 June 2012 |
| Creators | Redelinghuys, Michelle |
| Source Sets | South African National ETD Portal |
| Language | English |
| Detected Language | English |
| Type | Thesis |
| Format | application/pdf |
Page generated in 0.0025 seconds